Pfizer CentreOne Header Pfizer CentreOne Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Theriva Biologics

    Client Virtual Booth

    THERIVA BIOLOGICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Theriva Biologics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850
    Telephone
    Telephone
    (301) 417-4364
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://therivabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/theriva-biologics/
    Twitter
    Twitter
    https://twitter.com/TOVXBiologics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Theriva Biologics Reports Second Quarter 2023 Financial Results
    Theriva Biologics Reports Second Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/08/08/2720584/0/en/Theriva-Biologics-Reports-Second-Quarter-2023-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    08 Aug 2023
    Share Share
    Theriva Biologics Announces Key Progress in VIRAGE
    Theriva Biologics Announces Key Progress in VIRAGE

    https://www.globenewswire.com/news-release/2023/08/02/2716683/0/en/Theriva-Biologics-Announces-Key-Progress-in-VIRAGE-an-Ongoing-Multinational-Phase-2b-Trial-of-VCN-01-in-Combination-with-Chemotherapy-in-Pancreatic-Ductal-Adenocarcinoma.html

    GLOBENEWSWIRE
    02 Aug 2023
    Share Share
    Theriva Biologics to Discuss Second Quarter 2023 Financial Results
    Theriva Biologics to Discuss Second Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/08/01/2716378/0/en/Theriva-Biologics-to-Host-Conference-Call-and-Webcast-to-Discuss-Second-Quarter-2023-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    01 Aug 2023
    Share Share
    Theriva Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01
    Theriva Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01

    https://www.globenewswire.com/news-release/2023/06/27/2695780/0/en/Theriva-Biologics-Announces-Orphan-Drug-Designation-Granted-by-the-U-S-FDA-for-VCN-01-for-the-Treatment-of-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    27 Jun 2023
    Share Share
    Theriva Announces Appointment of Ramon Alemany, Ph.D., to Senior VP
    Theriva Announces Appointment of Ramon Alemany, Ph.D., to Senior VP

    https://www.globenewswire.com/news-release/2023/05/23/2674251/0/en/Theriva-Biologics-Announces-Appointment-of-Ramon-Alemany-Ph-D-to-Senior-Vice-President-of-Discovery.html

    GLOBENEWSWIRE
    23 May 2023
    Share Share
    Theriva Biologics Reports First Quarter 2023 Financial Results
    Theriva Biologics Reports First Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/05/11/2666648/0/en/Theriva-Biologics-Reports-First-Quarter-2023-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    11 May 2023
    Share Share
    Theriva Biologics to Host Conference Call & Webcast to Discuss 1Q 2023
    Theriva Biologics to Host Conference Call & Webcast to Discuss 1Q 2023

    https://www.globenewswire.com/news-release/2023/05/04/2661424/0/en/Theriva-Biologics-to-Host-Conference-Call-and-Webcast-to-Discuss-First-Quarter-2023-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    04 May 2023
    Share Share
    Theriva Announces Presentation of Data from Phase 1b/2a Trial of SYN-004
    Theriva Announces Presentation of Data from Phase 1b/2a Trial of SYN-004

    https://www.globenewswire.com/news-release/2023/04/13/2646140/0/en/Theriva-Biologics-Announces-Presentation-of-Data-from-Cohort-1-of-the-Phase-1b-2a-Clinical-Trial-of-SYN-004-ribaxamase-in-Allogeneic-Hematopoietic-Cell-Transplant-Recipients.html

    GLOBENEWSWIRE
    13 Apr 2023
    Share Share
    Theriva Biologics Reports 4Q and Full-Year 2022 Financial Results
    Theriva Biologics Reports 4Q and Full-Year 2022 Financial Results

    https://www.globenewswire.com/news-release/2023/03/30/2637573/0/en/Theriva-Biologics-Reports-Fourth-Quarter-and-Full-Year-2022-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    30 Mar 2023
    Share Share
    Theriva to Reschedule Conference to Discuss Fourth Quarter Financial Results
    Theriva to Reschedule Conference to Discuss Fourth Quarter Financial Results

    https://www.globenewswire.com/news-release/2023/03/24/2634313/0/en/Theriva-Biologics-to-Reschedule-Conference-Call-and-Webcast-to-Discuss-Fourth-Quarter-and-Full-Year-2022-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    24 Mar 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    lgm-pharma-2023-09-18

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search